Premium
Prevalence of antibody to hepatitis C virus in HBsAg‐negative chronic liver disease in Hong Kong using different assays
Author(s) -
Lai J. Y.,
Tam John S.,
Lam L. Y.,
Leung Nancy W. Y.
Publication year - 1992
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890370215
Subject(s) - medicine , hbsag , cirrhosis , gastroenterology , chronic liver disease , antibody , alcoholic liver disease , liver disease , hepatitis c virus , virus , immunology , hepatitis , virology , hepatitis b virus
The prevalence of anti‐HCV antibodies in Chinese patients with HBsAg‐negative chronic liver diseases was studied retrospectively. Anti‐HCV was detected by two different ELISAs. In 97 pa‐ tients with HBsAg‐negative chronic liver disease, 26 (27%) were anti‐HCV positive. Of 157 control subjects, only 1 (0.6%) was anti‐HCV positive (P < 0.001). Anti‐HCV was detected in 18 of 27 (67%) patients with post‐transfusion non‐A, non‐B (PTNANB) chronic hepatitis or cirrhosis, 5 of 25 (20%) patients with cryptogenic chronic hepatitis or cirrhosis, 2 of 33 (6%) patients with alcoholic liver disease, 1 of 5 (20%) patients with autoimmune chronic active hepatitis (AICAH), none of 4 patients with primary biliary cirrhosis (PBC), and none of 3 patients with fatty liver. The prevalence in this group of patients was lower when compared to reports from other countries. The addition of a urea washing step reduced false‐positivity in alcoholic and AICAH groups. The ELISA that employs three recombinant HCV antigens confirmed all positive results by an‐ other ELISA with the exception of one weakly positive result in the AICAH group and one in the alcoholic group. One patient in the PTNANB group was detected in addition by the second generation assay. In conclusion, ELISA with a urea wash proved to be useful in reducing falsepositivity, and the second generation assay proved to be a sensitive and specific test for anti‐HCV antibody. © 1992 Wiley‐Liss, Inc.